Innovita Biological Technology Co., Ltd. (SHA:688253)
China · Delayed Price · Currency is CNY 57.79
+0.12 (0.21%)
At close: Sep 23, 2026
SHA:688253 Market Cap
SHA:688253 has a market cap or net worth of 7.79 billion as of September 23, 2026. Its market cap has increased by 85.14% in one year.
Market Cap
7.79B
Enterprise Value
6.04B
Revenue
286.33M
Ranking
n/a
PE Ratio
155.53
Stock Price
57.79
ChartMarket Cap Chart
Since July 28, 2022, SHA:688253's market cap has increased from 4.49B to 7.79B, an increase of 73.59%. That is a compound annual growth rate of 14.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 7.79B | 91.48% |
| Dec 31, 2025 | 4.07B | -17.74% |
| Dec 31, 2024 | 4.95B | 45.41% |
| Dec 29, 2023 | 3.40B | 5.00% |
| Dec 30, 2022 | 3.24B | -27.82% |
| Jul 28, 2022 | 4.49B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chongqing Genrix Biopharmaceutical | 8.40B |
| Vcanbio Cell & Gene Engineering Corp., | 8.29B |
| Bio-Thera Solutions | 8.02B |
| Aurisco Pharmaceutical | 7.97B |
| Daan Gene | 7.89B |
| Beijing Hotgen Biotech | 7.78B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 7.47B |
| Novogene | 7.36B |